Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Mike Infante

Morgan Stanley · covers Industrials, Technology

Period: Reporting periods mapped to calendar 2024 Q4 – 2026 Q3 (8 quarters).

Questions
21on tracked calls
Challenge rate
14%3 of 21 questions
Companies
4questioned at least once
Reporting periods
8with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 21 of 21 questions from 4 companies

BRBroadridge Financial Solutions12 questions · 6 reporting periods · 3 of 12 challenging
BR company page →

Calendar 2026 Q2

how should we be thinking about your level of aggressiveness on the buyback from here?

Capital AllocationTranscript · FY2026 Q4 →
Show response

Tim reaffirmed balanced allocation (investment-grade rating, organic investment, dividend, M&A, buyback residual) but signaled heavier buybacks with shares seen as compelling value at 1.9x leverage.

how should we be thinking about the unit economics and how that might evolve?

PricingInnovation & R&DTranscript · FY2026 Q4 →
Show response

Asked by Michael Infante on for James Faucette. Tim said tokenized positions use existing rate schedules (registered for native, beneficial for custodial, pass-through-like for synthetic) and add complexity that drives position growth.

Calendar 2026 Q1

what's the gating item to seeing more Galaxy-like announcements in terms of your on-chain efforts?

Innovation & R&DDemandTranscript · FY2026 Q3 →
Show response

Tim said gating factor is capacity to engage partners, not demand. Expanding team to meet demand. Companies in pipeline tend to be digital asset ecosystem firms. For non-crypto corporates, depends on capital raising economics and investor demand. Speculated large upcoming IPOs could include tokenized sleeves as market catalyst.

how should we be thinking about your conviction in the durability of recurring revenue growth on a go-forward basis if closed sales performance doesn't inflect?

ChallengingRevenue GrowthGuidance ReliabilityTranscript · FY2026 Q3 →
Show response

Ashima quantified sales guidance delta at $40-45M at midpoint, translating to only 10-30bps revenue impact given conversion cycles. Positive drivers for FY27 include volume trends, existing $430M backlog, growth-accretive M&A, and internal growth. Will provide formal FY27 guidance in August.

Calendar 2025 Q4

how do you think about sort of the underlying mechanics of that spread and or, you know, whether or not you expect the spread to sort of remain consistent

Subscriber GrowthRevenue GrowthTranscript · FY2026 Q2 →
Show response

Tim framed it as revenue positions being the core metric with fractional shares and small managed accounts growing on top. Spread will fluctuate. Ashima added 11% revenue position growth still above long-term mid to high single-digit trend, with additional positions akin to backlog converting later.

how much is already sort of late stage from a contracting perspective? Or you know, sort of timeline of expected renewals versus truly jump on net new logos?

DemandGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Tim acknowledged H2 ramp needed but said origination up 20%+ is positive indicator. Closed largest-ever DLR sale to tier-one global bank last week. Deep pipeline mix of on-track and possible closings supports $290-330M guidance. Met with dozen+ client CEOs recently.

Calendar 2025 Q3

can you just walk through some of the puts and takes as to why EPS wouldn't similarly track towards the high end of the range, just given the high incremental margin nature of that event-driven rev...

ChallengingGuidance ReliabilityMarginTranscript · FY2026 Q1 →
Show response

Ashima explained revenue raise driven by iJoin and Signal acquisitions offsetting rate cuts, plus underlying business strength. Tim said early in year, reinvesting in tokenization, digital assets, shareholder engagement, AI and platform. Staying with EPS guidance is the right call.

do you intend to convert some of those holdings to cash, if at all, to sort of mitigate some of the GAAP volatility?

Capital AllocationInnovation & R&DTranscript · FY2026 Q1 →
Show response

Tim said expect GAAP volatility from Canton Coins which will be adjusted out. Plan to liquidate holdings over time but Canton Coins could become more valuable as network grows. Ashima added ~1 point impact to capital markets revenue, not significant at Broadridge scale.

Calendar 2025 Q2

is there any sort of qualitative color you can provide just in terms of how big of a closed sale driver DLR is at this point?

Innovation & R&DRegulation PolicyTranscript · FY2025 Q4 →
Show response

Tim said DLR not moving total sales needle but very material for the product. $200B daily volume larger than entire crypto market ex-Tether. Signed 8 new clients in FY25 including Tier 1s. Sponsored repo for treasury clearing driving adoption.

I'm just curious whether or not you're seeing any of that elongation and/or if you're just bullish on the growth and the composition of that pipeline that you can absorb some incremental elongation...

ChallengingDemandCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Tim acknowledged year-long elongation trend but said nothing incrementally worse now. Emphasized sales coming from areas of investment: voting choice, wealth platform, DLR repo, global post-trade. More strategic conversations than ever before.

Calendar 2025 Q1

Is there a way to quantify what revenue growth maybe would have been if the size of positions was more in line with historical trends

Subscriber GrowthRevenue GrowthTranscript · FY2025 Q3 →
Show response

Ashima broke down 15% total vs. 11% revenue position growth. Also noted only 75-80% of regulatory revenue is directly tied to position growth, with international proxy and other comms growing slower.

where are you just in that journey from transitioning for a license to subscription?

Revenue GrowthCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Tim explained license model typically from acquired companies. Well advanced in transition but a tail remains. Q3 wealth license renewal shifted to Q4, creating quarterly noise.

CPAYCorpay4 questions · 3 reporting periods · 0 of 4 challenging
CPAY company page →

Calendar 2026 Q2

You have previously spoken about the 40% of your flows within cross border that are still on SWIFT.

Innovation & R&DCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Ron said it's about speed and cost, they've done ~40,000 transactions on the JPM private blockchain, and could move half of SWIFT wires onto such rails by year-end.

Calendar 2026 Q1

Anything we should just be mindful of in terms of the Q2 cross-border comp?

Trade TariffsRevenue GrowthTranscript · FY2026 Q1 →
Show response

Peter said nothing specific to flag. Volatility across the world created opportunity to display capabilities and gain business. Pointed to upcoming cross-border teach-in describing a $160 trillion market with only 1% market share.

is that 1 to 2 points of contribution to cross-border still the right place for'26?

Show response

Ron reported 3-4 signed contracts at $5M run rate, 50 accounts in pipeline. Most interesting finding: FIs most interested in multicurrency bank account product even more than payment capabilities. Slower sales cycle than end businesses but formula is working. Still bullish on contribution.

Calendar 2025 Q4

the mechanism by which we'll actually start to see some medium-term compression of Stablecoin off-ramp costs

Innovation & R&DCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Ron reiterated rails are insignificant cost. Getting 50-60 bps on trades (sometimes 100 depending on customer) mostly because of liquidity and compliance, not rails. Does not see compression as high risk. Compared stablecoin hype to EV -- more written and said than actually used.

PAYXPaychex4 questions · 3 reporting periods · 0 of 4 challenging
PAYX company page →

Calendar 2026 Q3

how are you thinking about the risk of clients downselling into lower-cost offerings within the PEO

Show response

Bob said Paychex has not seen PEO downselling and has not assumed further retention gains, having baked in only the trends seen so far.

Calendar 2025 Q3

Can you maybe just paint the picture for us in terms of the customer profile who would be most likely to initially adopt some of these capabilities? How you think about some of the go-to-market dyn...

Revenue GrowthProduct LaunchTranscript · FY2026 Q1 →
Show response

Management addressed Bill.com partnership go-to-market and PEO mix dynamics.

was there anything incremental either in terms of PEO versus ASO mix shift and or employees opting for lower-cost health plans and maybe how that trended sequentially?

Revenue GrowthProduct LaunchTranscript · FY2026 Q1 →
Show response

Follow-up on Bill.com partnership go-to-market and PEO mix dynamics.

Calendar 2024 Q4

I'm just curious how you think about the partnership channel and whether or not that's a source of incremental investment for you

Competitive DynamicsInnovation & R&DTranscript · FY2025 Q2 →
Show response

Gibson noted existing embedded/white-label capabilities especially in CPA micro area. Open to broader partnerships where mutual value exists. More to come.

ADPADP1 question · 1 reporting period · 0 of 1 challenging
ADP company page →

Calendar 2025 Q3

your perspective on the stablecoin topic potentially being used as a mechanism to pay employees

Innovation & R&DRegulation PolicyTranscript · FY2026 Q1 →
Show response

Maria said they are monitoring the regulatory environment closely and preparing for all possibilities on payment rails. Strategic imperative to support however client employees want to get paid.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
BR Broadridge Financial Solutions1225%3 of 12 questions
CPAY Corpay40%none of 4 questions
PAYX Paychex40%none of 4 questions
ADP ADP1—Rate withheld: fewer than 3 questions
  • BR
    Broadridge Financial Solutions · 12 questions
    25%3 of 12 questions
  • CPAY
    Corpay · 4 questions
    0%none of 4 questions
  • PAYX
    Paychex · 4 questions
    0%none of 4 questions
  • ADP
    ADP · 1 question
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q410%none of 1 question1
2025 Q120%none of 2 questions1
2025 Q2250%1 of 2 questions1
2025 Q3520%1 of 5 questions3
2025 Q430%none of 3 questions2
2026 Q1425%1 of 4 questions2
2026 Q230%none of 3 questions2
2026 Q310%none of 1 question1
  1. 2024 Q41 question · challenge rate 0% (none of 1 question) · 1 company
  2. 2025 Q12 questions · challenge rate 0% (none of 2 questions) · 1 company
  3. 2025 Q22 questions · challenge rate 50% (1 of 2 questions) · 1 company
  4. 2025 Q35 questions · challenge rate 20% (1 of 5 questions) · 3 companies
  5. 2025 Q43 questions · challenge rate 0% (none of 3 questions) · 2 companies
  6. 2026 Q14 questions · challenge rate 25% (1 of 4 questions) · 2 companies
  7. 2026 Q23 questions · challenge rate 0% (none of 3 questions) · 2 companies
  8. 2026 Q31 question · challenge rate 0% (none of 1 question) · 1 company

Topics

Topics tagged on this analyst’s questions.

  • Innovation & R&D8
  • Revenue Growth8
  • Competitive Dynamics5
  • Demand4
  • Guidance Reliability3
  • Capital Allocation2
  • Subscriber Growth2
  • Regulation Policy2
  • Product Launch2
  • Pricing1
Show all 13 topics
  • Margin1
  • Trade Tariffs1
  • M&A1